Skip to main content
Healthcare

STAT+: A possible comeback for a failed sickle cell gene therapy

STAT+: A possible comeback for a failed sickle cell gene therapy

Feed excerpt — reported by STAT News

Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy…

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.